Home › Prostate Cancer › Illinois › Arlington Heights
Prostate Cancer clinical trials in Arlington Heights, IL
3 studies for Prostate Cancer are looking for participants at sites in and around Arlington Heights (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Advocate Good Shepherd Hospital, Barrington · 9 mi away
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- Advocate Good Shepherd Hospital, Barrington · 9 mi away
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RecruitingPhase 1
- Illinois Cancer Specialists, Arlington Heights
- Comprehensive Urologic Care, Lake Barrington · 12 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN42 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Arlington Heights
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer12 studies
- Lung Cancer9 studies
- Heart Failure7 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Ulcerative Colitis6 studies
- Colon Cancer6 studies
- Ovarian Cancer5 studies
- Obesity4 studies
- Overweight4 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.